Complete pathological responses in locally advanced rectal cancer after preoperative IMRT and integrated-boost chemoradiation

Strahlentherapie und Onkologie

Volumn 190, Issue 6, 2014, Pages 515-520

  Hernando Requejo, Ovidio ^a,c,d   López, Mercedes ^a   Cubillo, Antonio ^b,c   Rodriguez, Almudena ^a   Ciervide, Raquel ^a   Valero, Jeannette ^a   Sánchez, Emilio ^a   Garcia Aranda, Mariola ^a   Rodriguez, Jesus ^b,c   Potdevin, Guillermo ^a   Rubio, Carmen ^a,c  

^a HOSPITAL UNIVERSITARIO HM SANCHINARRO   (Spain)

^b Centro Integral Oncológico Clara Campal HM CIOCC   (Spain)

^c UNIVERSIDAD SAN PABLO CEU   (Spain)

^d CEU Universities   (Spain)

Author keywords

Chemoradiation; Downstaging; Intensity modulated radiotherapy; Pathological complete response; Rectal carcinoma

Indexed keywords

CAPECITABINE;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CHEMORADIOTHERAPY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PELVIS LYMPH NODE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RECTUM CANCER; TREATMENT RESPONSE; TUMOR VOLUME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, INTENSITY-MODULATED; RECTAL NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84901604798     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-014-0650-0     Document Type: Article

References (32)

1. Nelson H, Petrelli N, Carlin A et al (2001) Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 93:583-596
2. Jemal A, Siegel R, Ward E et al (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71-96
3. Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731-1740
4. Rödel C, Martus P, Papadopoulos T et al (2005) Prognostic significance of tumor regresión after preoperative chemoradiotherapy for rectal cáncer. J ClinOncol 23:8688-8696
5. Kim TH, Chang HJ, Kim DY et al (2010) Pathological nodal classification is the most discriminating prognostic factor for disease-free survival in rectal cáncer patients treated with preoperative chemoradiotherapy and curative resection. Int J Radiat Oncol Biol Phys 77:1158-1165
6. Lee JH, Kim SH, Kim JG et al (2011) Preoperative chemoradiotherapy (CRT) followed by laparoscopic surgery for rectal cancer: predictors of the tumor response and the long-term oncologic outcomes. Int J Radiat Oncol Biol Phys 82:431e438
7. Bosset JF, Collette L, Calais G et al (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Eng J Med 355:1114-1123
8. Bosset JF, Magnin V, Maingon P et al (2000) Preoperative radiochemotherapy in rectal cancer: longterm results of a Phase II trial. Int J Rad Oncol Biol Phys 46:323-327
9. Rödel C, Grabenbauer GG, Papadopoulos T et al (2003) Phase I-II trial of capecitabine, oxaliplatin and radiation for rectal cancer. J Clin Oncol 21:3098-3104
10. Machiels JP, Duck L, Honhon B et al (2005) Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer. The RadiOxCape study. Ann Oncol 16:1898-1905
11. Hospers GA, Punt CJ, Tesselaar ME et al (2007) Preoperative chemoradiotherapy with capecitabine and oxaliplatin in locally advanced rectal cancer. A phase I-II multicenter study of the Duch Colorectal Cancer Group. Ann SurgOncol 14:2773-2779
12. Gerard JP, Azria D, Gourgou-Bourgade S et al (2010) Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer. Results of the Phase III trial ACCORD 12/0405-Prodige 2. J ClinOncol 28:1638-1644
13. Winkler J, Zipp L, Knoblich J et al (2012) Simultaneous neoadjuvant radiochemotherapy with capecitabine and oxaliplatin for locally advanced rectal cancer. Strahlentherapie und Onkologie 188:377-382
14. Rödel C, Liersch T, Hermann RM et al (2007) Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer. J ClinOncol 25 110-117
15. Aschele CP, Cordio S, Rosati G et al (2009) Preoperative fluorouracil (FU)-based chemoradiation with and without weekly oxaliplatin in locally advanced rectal cancer: pathologic response analysis of the Studio Terapia Adiuvante Retto (STAR)-01 randomized phase III trial. J Clin Oncol 27(suppl): 170s, abstr CRA4008
16. Fu KK, Pajak TF, Trotti A et al (2000) A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48:7-16
17. Kim DY, Kim TH, Jung KH et al (2006) Preoperative chemoradiotherapy with concomitant small field boost irradiation for locally advanced rectal cancer: a multi-institutional phase II study (KROG 04-01). Dis Colon Rectum 49:1684-1691
18. Jong Hoon Lee, Dae Yong Kim, Taek-Keun Nam et al (2012) Long-term follow-up of preoperative pelvic radiation therapy and concomitant boost irradiation in locally advanced rectal cancer patients: a multi-institutional phase II study (KROG 04-01) Int J Radiat Oncol Biol Phys 84:955-961
19. Cubillo A, Hernando-Requejo O, Garcia-Garcia E et al (2014) A prospective pilot study of targetguided personalized chemotherapy with intensitymodulated radiotherapy in patients with early rectal cancer. AM J Clin Oncol 37:117-121
20. Freedman GM, Meropol NJ, Sigurdson ER et al (2007) Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 67:1389-1393
21. Jin-luan Li, Jia-fu Ji, Xiao-fan Li et al (2012) Preoperative concomitant boost intensity-modulated radiotherapy with oral capecitabine in locally advanced mid-low rectal cancer: a phase II trial. Radiother Oncol 102:4-9
22. Chua YJ, Barbachano Y, Cunningham D et al (2010) Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRIdefined poor-risk rectal cancer: a phase 2 trial. Lancet Oncol 11:241-248
23. Ballonoff A, Kavanagh B, McCarter M et al (2008) Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trial. Am J Clin Oncol 31:264-270
24. De Paoli A, Chiara, Luppi G et al (2006) Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: multicentric phase II study. Ann Oncol 17:246-251
25. Debucquoy A, Roels S, Goethals L et al (2009) Double blind randomized phase II study with radiation + 5-fluorouracil ± celecoxib for resectable rectal cancer. Radiother Oncol 93:273-278
26. Francois Y, Nemoz CJ, Baulieux J et al (1999) Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 17:2396
27. Pettersson D, Cedermark B, Holm T et al (2010) Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer. Br J Surg 97:580-587
28. Glynne-Jonnes R, Mawdsley S et al (2006) Alternative clinical endpoints in rectal cancer-are we getting closer? Ann Oncol 17:1239-1248
29. Dekker JW, Peeters KC, Putter H et al (2010) Metastatic lymph node ratio in stage III rectal cancer: prognostic significance in addition to the 7th edition of the TNM classification. Eur J Surg Oncol 36:1180-1186
30. Medical research Council Rectal Cancer Working Party (1996) Randomised trial of surgery versus radiotherapy followed by surgery for potentially operable advanced rectal cáncer. Lancet 348:1605-1610
31. Mawdsley S, Glynne-Jones R, Grainger J et al (2005) Can the histopathological assessment of the circumferential margin following pre-operative pelvic chemo-radiotherapy for T3/4 rectal cancer predict for three year disease free survival? Int J Radiation Oncol Biol Phys 63:745-752
32. Sautter-Bihl ML, Hohenberger W, Fietkau R et al (2013) Rectal cancer. Strahlentherapie und Onkologie 189:105-110